Navigation Links
ExonHit and bioMerieux Amend Their Strategic Partnership
Date:1/9/2008

PARIS, January 9 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, announced today that it has signed an amendment to its strategic partnership with bioMerieux in the field of cancer diagnostics. Under the terms of the amendment, ExonHit will gain commercial rights on the diagnostic kits developed through the partnership and bioMerieux will have a greater flexibility to initiate new research and development projects in that field.

The partnership, initiated in October 2005, is based on ExonHit's gene expression analysis expertise and intellectual property, and on bioMerieux's know-how in the field of in vitro diagnostics. Its goal is to develop DNA microarrays to detect cancer markers in blood samples. DNA microarrays are perfectly suitable to detect many nucleic acids allowing the identification of multigenic diseases such as cancers.

Three programs to develop blood-based cancer diagnostics are currently underway: the first is on breast cancer for which a prospective study is ongoing, the second is aimed at colorectal cancers, and the third, targeting prostate cancer, was initiated in January 2007.

As of now, the commercial rights granted will allow ExonHit to market the diagnostic kits developed through the partnership to pharmaceutical companies, or to hospitals taking part in clinical studies, in order to help them recruit patients for their clinical studies.

"This amendment is a major step forward in ExonHit's development because it allows us to consider generating our own source of revenues from products based on our technology which are issued from the collaboration" declared Bruno Tocque, Chairman of the Management Board of ExonHit. "To this end, we are modifying our laboratories and our processes in order to best meet the pharmaceutical industry's specific requirements."

About ExonHit Therapeutics

http://www.exonhit.com
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
2. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Halozyme Therapeutics Amends Stockholder Rights Plan
5. Beanstalk Capital Ltd. and iCo Therapeutics Inc. amend arrangement agreement
6. Genmab Amends HuMax-CD4 Pivotal Study in CTCL
7. Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study
8. Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense
9. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
10. 3 strikes, youre out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause
11. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... CAMBRIDGE, Mass., Dec. 2 TechConn...in technology development and product integration ...d the December 11th deadline for technology abstra...4th year, TechConnect World, in association with t...nd the Clean Technology and Sustainable Industries...
(Date:12/2/2009)...C CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Ze...ny"), a global biopharmaceutical company focused o...that the U.S. Food and Drug Administration (FDA) h...s PI3K/Akt pathway inhibitor compound, perifosine ...ry multiple myeloma. Keryx Biopharmaceuticals, Inc...
(Date:12/1/2009)...E VILLAGE, Nev., Dec. 1 ...nnounced revenue guidance for the fourth quarter e...n, as compared with $69 million for the fourth qua...lts was the first of two installment payments of $...h quarter 2008 results was a one-time $1.8 million...
(Date:12/1/2009)..., CAMBRIDGE, Mass., Dec. 1 To addr...y and to promote its potential, a group of individ...Synthetic Biology Industry Association (SynBIA) in...he association is to provide a forum for individua...ustry, address its opportunities and its challenge...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2
... The National Academy of,Sciences (NAS) Council a...ief technology officer and executive vice presiden... the Industrial Application of Science. This,prize... intrinsic,scientific importance and with signific...s case, the improvement of crops through biotechno...
...s are attractive candidates for use as the active ...ces. However, it has proven incredibly difficult t...t of the approaches for lining up carbon nanotubes...e devices and are not readily scalable to the leve...sed chips. Now, this seemingly intractable problem...
... 23 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH)...,today it will be participating in the Wachovia Se...anuary 30, 2008, at 10:15 a.m. Eastern Time., A l...a Zimmer,s,Investor Relations website at http://i...for replay following the conference., About the C...
Other Biology Technology:National Academy of Sciences Recognizes Monsanto's Chief Technology Officer for Development of Agricultural Biotechnology 2Nanotubes go with the flow 2
(Date:12/3/2009)..., The 30-year record low in Antarctic snowmelt th...likely due to concurrent strong positive phases fo...n Oscillation) and SAM (Southern Hemisphere Annula... Professor of Earth & Atmospheric Sciences at The ... who is also on the doctoral faculty at the CUNY G...
(Date:12/2/2009)..., , PHILADELPHIA New study results strengthen th... long period of time have an increased risk for de...or other risk factors. , "This provides one mor...ble," said senior author Michael J. Thun, M.D., M....eillance research at the American Cancer Society. ...
(Date:12/2/2009)..., , PHILADELPHIA Mexican-American adolescents ex...re likely to pick up the habit themselves, and thi...ted with smoking initiation, according to new stud...r smoking in the United States and highlights the ...tion Framework Convention on Tobacco Control, whic...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Breast Cancer Art Shares Journeys of Hope Reconstruction 60018 1Breast Cancer Art Shares Journeys of Hope Reconstruction 60018 2New Hospitals Therapeutic Design Supports Healing Green Practices 60015 1New Hospitals Therapeutic Design Supports Healing Green Practices 60015 2New Hospitals Therapeutic Design Supports Healing Green Practices 60015 3New Hospitals Therapeutic Design Supports Healing Green Practices 60015 4SRI International Researcher Receives International Speech Communication Association 28ISCA 29 Fellow Award 60012 1SRI International Researcher Receives International Speech Communication Association 28ISCA 29 Fellow Award 60012 2SRI International Researcher Receives International Speech Communication Association 28ISCA 29 Fellow Award 60012 3
... Malaria and dengue fever will be the early targe...barcodes" to detect disease. , The University of...(UW) are poised to launch the research after Queen...he National and International Research Alliances P... of two debilitating mosquito-borne diseases, mala...
... Even if you eat right and exercise regularly, ch...tack or stroke. But thanks to new findings by rese...lly shift in your favor. Two unrelated studies rec...http://www.fasebj.org ) describe findings on ather...s of lives. , Both studies involved experiments i...
... , SANTA CRUZ, CA--Huge numbers of fish, seabirds...d discarded after being inadvertently caught durin...s problem is an ongoing challenge to the fishing i.... One recent proposal would compensate for bycatch...t a new analysis suggests that this strategy could...
Other Biology News:New discoveries from Harvard and Baylor get to the heart of cardiovascular disease 2New discoveries from Harvard and Baylor get to the heart of cardiovascular disease 3New study raises concerns about proposed mitigation strategy for marine bycatch 2
Mouse Anti-Rabbit T LYMPHOCYTES Monoclonal Antibody, Unconjugated, Clone KEN-5 from AbD Serotec
Apoptotic DNA Laddering Kit - Tissue Supplement from R&D Systems
Rabbit Anti-GLYCINE Polyclonal Antibody, Unconjugated from AbD Serotec
...243 provides all the materials necessary for the i...CMV antigen studies analysis. Kit Components: ... bottle containing 220 mL of buffered ammonium chl...g No. 5113) One bottle containing 220 mL of PBS, f...
Biology Products: